Esperion Therapeutics
ESPR
#6750
Rank
S$1.04 B
Marketcap
S$4.07
Share price
0.00%
Change (1 day)
70.95%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): S$0.10 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.41 Billion. In 2025 the company made an earning of S$81.58 Million, an increase over its 2024 earnings that were of S$9.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.10 B24.73%
2025 S$81.58 M749.49%
2024 S$9.6 M-104.99%
2023 -S$0.2 Billion-15.03%
2022 -S$0.23 Billion-20.61%
2021 -S$0.29 Billion84.28%
2020 -S$0.16 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.26 Billion19.57%
2017 -S$0.22 Billion125.39%
2016 -S$95.46 Million51.43%
2015 -S$63.04 Million36.45%
2014 -S$46.2 Million43.55%
2013 -S$32.19 Million145.26%
2012 -S$13.13 Million
2002 -S$37.41 Million-7.81%
2001 -S$40.58 Million15.03%
2000 -S$35.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.55 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.59 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.69 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$33.39 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA